Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

Update Il y a 4 ans
Reference: NCT00904371

Woman and Man

  • | Country :
  • Slovenia
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The study is designed to evaluate the effect of treatment with Micardis/MicardisPlus on blood pressure and its ability to reduce different indicated cardiovascular risks. Further on, the study will evaluate the current antihypertensive treatment pattern in the daily practice among the patient population at increased cardiovascular risk.


Inclusion criteria

  • Hypertension ,Cardiovascular Diseases

Links